Vanguard Group’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $254K | Buy |
|
|||||
|
2023
Q4 | $163K | Buy |
|
|||||
|
2023
Q3 | $161K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $93.6K | Buy |
|
|||||
|
2022
Q4 | $121K | Buy |
|
|||||
|
2022
Q3 | $46K | Sell |
|
|||||
|
2022
Q2 | $73K | Sell |
|
|||||
|
2022
Q1 | $549K | Hold |
|
|||||
|
2021
Q4 | $817K | Hold |
|
|||||
|
2021
Q3 | $1.57M | Buy |
|
|||||
|
2021
Q2 | $1.62M | Buy |
|
|||||
|
2021
Q1 | $1.32M | Sell |
|
|||||
|
2020
Q4 | $1.26M | Sell |
|
|||||
|
2020
Q3 | $1.47M | Sell |
|
|||||
|
2020
Q2 | $2.94M | Sell |
|
|||||
|
2020
Q1 | $4.13M | Sell |
|
|||||
|
2019
Q4 | $10.3M | Sell |
|
|||||
|
2019
Q3 | $17.2M | Sell |
|
|||||
|
2019
Q2 | $47.5M | Sell |
|
|||||
|
2019
Q1 | $91.3M | Buy |
|
|||||
|
2018
Q4 | $95.1M | Buy |
|
|||||
|
2018
Q3 | $106M | Buy |
|
|||||
|
2018
Q2 | $139M | Buy |
|
|||||
|
2018
Q1 | $104M | Buy |
|
|||||
|
2017
Q4 | $93.9M | Buy |
|
|||||
|
2017
Q3 | $101M | Sell |
|
|||||
|
2017
Q2 | $84.9M | Buy |
|
|||||
|
2017
Q1 | $86.9M | Buy |
|
|||||
|
2016
Q4 | $73.4M | Sell |
|
|||||
|
2016
Q3 | $84M | Sell |
|
|||||
|
2016
Q2 | $109M | Buy |
|
|||||
|
2016
Q1 | $92.8M | Buy |
|
|||||
|
2015
Q4 | $140M | Buy |
|
|||||
|
2015
Q3 | $84.7M | Buy |
|
|||||
|
2015
Q2 | $104M | Buy |
|
|||||
|
2015
Q1 | $99.4M | Buy |
|
|||||
|
2014
Q4 | $116M | Buy |
|
|||||
|
2014
Q3 | $95.8M | Buy |
|
|||||
|
2014
Q2 | $93.8M | Buy |
|
|||||
|
2014
Q1 | $105M | Buy |
|
|||||
|
2013
Q4 | $77.5M | Buy |
|
|||||
|
2013
Q3 | $86.7M | Buy |
|
|||||
|
2013
Q2 | $80.9M | Buy |
|